RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Evofem Biosciences Stock

Evofem Biosciences Market capitalization 2024

Evofem Biosciences Market capitalization

11.22 M USD

Ticker

EVFM

ISIN

US30048L1044

WKN

A2JBZC

In 2024, Evofem Biosciences's market cap stood at 11.22 M USD, a -83.11% increase from the 66.42 M USD market cap in the previous year.

The Evofem Biosciences Market capitalization history

YEARMarket Capitalization (undefined USD)
20231.83
20220.12
20210.18
20200.25
20190.19
2018207.84
201732.94
201626.07
2015215.24
201432.1
2013-
2012-

Evofem Biosciences Aktienanalyse

What does Evofem Biosciences do?

Evofem Biosciences Inc is a biochemistry company based in San Diego, California, that focuses on developing products to enhance women's sexual and reproductive health. The company, founded in 2001 by a group of scientists and doctors, aims to provide women with more effective methods of contraception and treatment for infectious diseases. Evofem Biosciences is an innovative biotech company specializing in the development of women's lifestyle and healthcare products, with a focus on birth control and the prevention of sexually transmitted infections (STIs). These products are developed using the company's own technology, which is based on a novel chemical binder and has proven to be particularly effective and safe. Evofem Biosciences' products are used by women around the world to protect themselves against unintended pregnancy and STIs. In the United States, the company is known as the only one that exclusively focuses on the development and marketing of women's products. The current products of Evofem Biosciences primarily focus on contraception. For example, the company has developed and markets a vaginal gel called "Phexxi." Phexxi is a hormone-free contraceptive that is used as needed to block sperm from reaching the egg. It was designed to provide women with a new option for contraception when hormonal contraceptives are not suitable due to side effects or other reasons. Another product in Evofem Biosciences' pipeline is an antimicrobial gel developed for the prevention of STIs, including chlamydia and gonorrhea. The gel is based on the same technology as Phexxi and is currently in phase III of clinical trials. Evofem Biosciences also operates a clinical research department focused on reproductive health and oncology, including breast cancer. This research aims to develop new diagnostic procedures and therapies to improve outcomes for women worldwide. Overall, Evofem Biosciences is a company that focuses on the needs of women and holds a leading position in the industry. Since its founding, the company has maintained its focus and goals, successfully developing and bringing innovative products to market over the past 20 years. It is expected that the company will continue to bring products to market in the future that meet the needs of women worldwide and definitively contribute to improving their sexual and reproductive health. Evofem Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Evofem Biosciences's Market Capitalization

Evofem Biosciences's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Evofem Biosciences's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Evofem Biosciences's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Evofem Biosciences’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Evofem Biosciences stock

What is the current Evofem Biosciences market capitalization?

The current market capitalization of Evofem Biosciences is 11.22 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Evofem Biosciences.

How has the market capitalization of Evofem Biosciences developed in recent years?

The market capitalization of Evofem Biosciences has increased/decreased by -83.11% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Evofem Biosciences?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Evofem Biosciences?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Evofem Biosciences have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Evofem Biosciences pay?

Over the past 12 months, Evofem Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Evofem Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Evofem Biosciences?

The current dividend yield of Evofem Biosciences is .

When does Evofem Biosciences pay dividends?

Evofem Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Evofem Biosciences?

Evofem Biosciences paid dividends every year for the past 0 years.

What is the dividend of Evofem Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Evofem Biosciences located?

Evofem Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Evofem Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Evofem Biosciences from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

When did Evofem Biosciences pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Evofem Biosciences in the year 2023?

In the year 2023, Evofem Biosciences distributed 0 USD as dividends.

In which currency does Evofem Biosciences pay out the dividend?

The dividends of Evofem Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Evofem Biosciences

Our stock analysis for Evofem Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evofem Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.